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After publication of this work [1] we noticed the following
errors:
The surname of the first author was incorrectly written as
‘Yamenel’ and should be ‘Yamanel.’
In the Study Protocol section of the materials and methods,
the units for APC dosage should be ‘µg/kg’ not ‘mg/kg.’
Please see the corrected section below.
There is a spelling mistake in the fourth paragraph of the
discussion. ‘Refect’ should read ‘reflect.’
Study Protocol
After the stabilization period, 45 male rats were randomly
divided into three groups. Rats in group I (control group;
n = 15) underwent laparotomy with manipulation of the
pancreas (sham procedure) and received 10 ml/kg saline
intravenously (single dose). Groups II and III underwent
laparotomy with induction of ANP. Rats in group II (positive
control; n = 15) received saline, as in group I but 6 hours after
induction of ANP. Rats in group III (treatment group; n = 15)
received 100 µg/kg recombinant human APC (Drotrecogin
alfa [activated]; Xigris; Lilly, Istanbul, Turkey) intravenously
(single dose) 6 hours after induction of ANP. Twenty-four
hours after induction of ANP, all surviving animals were killed
by intracardiac infection of pentobarbital (200 mg/kg). Blood
samples were taken from the heart before the animals were
killed in order to measure serum amylase, TNF-α, and IL-6.
Animals that died before the end of the study (four in group II
and two in group III) were excluded from the analysis.
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